Published in J Med Chem on October 01, 1993
Palladium-catalyzed asymmetric allylic alkylation of 3-aryloxindoles with allylidene dipivalate: a useful enol pivalate product. Angew Chem Int Ed Engl (2013) 0.76
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med (1997) 5.10
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev (1994) 2.39
Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci U S A (1994) 2.29
Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci U S A (1983) 1.65
Nalbuphine. Drug Alcohol Depend (1985) 1.30
Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A (1984) 1.22
(+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol (1985) 1.16
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol (2000) 1.12
Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors. J Med Chem (1986) 1.11
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors. J Med Chem (1985) 1.09
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs. J Med Chem (2000) 1.05
Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem (1980) 1.01
Peptides as receptor selectivity modulators of opiate pharmacophores. J Med Chem (1986) 1.00
Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem (1979) 0.97
2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action. J Med Chem (1998) 0.94
Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (1997) 0.94
The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells. Endocrinology (1981) 0.93
The hydrolysis of phosphatidylcholine by phospholipase A2 in hamster heart. Can J Biochem Cell Biol (1984) 0.92
Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine. Neuropsychopharmacology (1988) 0.91
An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. Br J Clin Pharmacol (2005) 0.88
Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. J Pharmacol Exp Ther (1986) 0.87
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. Bull Exp Biol Med (2001) 0.87
The purification and characterization of a phospholipase A in hamster heart cytosol for the hydrolysis of phosphatidylcholine. J Biol Chem (1987) 0.86
Light sensitive zinc content of protein fractions from bovine rod outer segments. Biochem Biophys Res Commun (1976) 0.85
A multifunctional cyclic nucleotide- and Ca2+-independent protein kinase from rabbit skeletal muscle. Biochem Biophys Res Commun (1982) 0.84
Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology (1989) 0.83
Selective reversible and irreversible ligands for the kappa opioid receptor. J Med Chem (1992) 0.82
High-throughput genomic and proteomic analysis using microarray technology. Clin Chem (2001) 0.82
Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices. J Pharmacol Exp Ther (1994) 0.82
Synthesis and opioid activity of 7-oxygenated 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolin-9-ols. J Med Chem (1994) 0.81
Differential interaction of rabbit skeletal muscle phosphorylase kinase isozymes with calmodulin. J Biol Chem (1980) 0.80
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci (1999) 0.79
Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent. Mol Cell Biol Res Commun (2000) 0.79
[3H]beta-funaltrexamine binds covalently to brain opioid receptors. Eur J Pharmacol (1985) 0.78
Bivalent opioid peptide analogues with reduced distances between pharmacophores. Life Sci (1987) 0.78
Selective sigma receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol (1989) 0.78
Binding of thrombin to human platelet plasma membranes. Biochim Biophys Acta (1978) 0.78
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels. Life Sci (2003) 0.77
Dopaminergic inhibition of ionophore A23187-stimulated release of prolactin from rat anterior pituitary cells. J Biol Chem (1980) 0.77
[3H]linopirdine (DuP 996) labels a novel binding site in rat brain involved in the enhancement of stimulus-induced neurotransmitter release: autoradiographic localization studies. Brain Res (1992) 0.77
Piperidinyltetralin sigma ligands. J Med Chem (1994) 0.77
Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding. Psychopharmacology (Berl) (1987) 0.76
Unique properties of norepinephrine release from terminals arising from the locus coeruleus: high potassium sensitivity and lack of linopirdine (DuP 996) enhancement. Neurosci Lett (1993) 0.76
Antiinflammatory 4,5-diarylpyrroles: synthesis and QSAR. J Med Chem (1994) 0.76
[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol (2000) 0.76
[Dependence of the pump function of the isolated rat heart on the functional activity of sigma receptors during reperfusion]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
Modification of the enkephalin "message" with an artificial polycationic C-terminus. J Med Chem (1991) 0.75
[The use of delta-receptor antagonist DuP 734 for correction of the contractile diastolic cardiac dysfunction in reperfusion injury and oxidative stress]. Eksp Klin Farmakol (2000) 0.75
Synthesis of (1',2'-trans)-3-phenyl-1-[2'-(N-pyrrolidinyl)cyclohexyl]pyrrolid -2-ones as kappa-selective opiates. J Pharm Sci (1990) 0.75
Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol (1991) 0.75
Phosphorylation and activation of red skeletal muscle phosphorylase kinase isozyme. J Biol Chem (1982) 0.75
[3H]DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'- oxoethyl)-piperidine HBr]: a receptor binding profile of a high-affinity novel sigma receptor ligand in guinea pig brain. J Pharmacol Exp Ther (1992) 0.75
Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence. J Pharmacol Exp Ther (1999) 0.75
Photoinactivation of the mu opioid receptor using a novel synthetic morphiceptin analog. Eur J Pharmacol (1987) 0.75
DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects. J Pharmacol Exp Ther (1992) 0.75
The effects of detergents on CDP-choline:1,2-diacylglycerol phosphocholine transferase from hamster heart. Can J Biochem Cell Biol (1984) 0.75
Use of hydrophilic diamines for bridging of two opioid peptide pharmacophores. Synthesis and receptor binding of two new analogues. Int J Pept Protein Res (1991) 0.75
(+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] but not (-)-3-PPP produces (+)-N-allylnormetazocine-like (SKF 10,047) discriminative stimuli. Life Sci (1986) 0.75
EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist. J Pharmacol Exp Ther (1993) 0.75
Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines. J Med Chem (1999) 0.75
[3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo. J Pharmacol Exp Ther (1993) 0.75
Differential effects of anesthetics on phosphatidylethanolamine biosynthesis in hamster tissue. Biochim Biophys Acta (1983) 0.75
Discriminative stimulus properties of a sigma receptor agonist in the rat: role of monoamine systems. Eur J Pharmacol (1987) 0.75
Effects of diazacholesterol, triparanol, and beta-sitosterol on egg cholesterol deposition in coturnix quail. Poult Sci (1979) 0.75
Novel piperidine sigma receptor ligands as potential antipsychotic drugs. J Med Chem (1992) 0.75
[The contribution of antioxidant enzymes in the cardioprotective effect of opioids during oxidative stress]. Vopr Med Khim (2001) 0.75
[Stimulation of peripheral delta1-opioid receptors as a method of preventing ischemic and reperfusion arrhythmia: role of K(ATP)-channels]. Eksp Klin Farmakol (2002) 0.75
Effects of the memory enhancer linopirdine (Dup 996) on cerebral glucose metabolism in naive and hypoxia-exposed rats. Brain Res (1993) 0.75
Structure-activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists. Bioorg Med Chem (1999) 0.75